416 related articles for article (PubMed ID: 25493221)
1. Positron emission tomography to assess hypoxia and perfusion in lung cancer.
Verwer EE; Boellaard R; van der Veldt AA
World J Clin Oncol; 2014 Dec; 5(5):824-44. PubMed ID: 25493221
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide imaging of hypoxia: Where are we now? Special attention to cancer of the cervix uteri.
Mokoala KMG; Lawal IO; Jeong JM; Sathekge MM; Vorster M
Hell J Nucl Med; 2021; 24(3):247-261. PubMed ID: 34954786
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
Apostolova I; Wedel F; Brenner W
Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer.
Sanduleanu S; Wiel AMAV; Lieverse RIY; Marcus D; Ibrahim A; Primakov S; Wu G; Theys J; Yaromina A; Dubois LJ; Lambin P
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455922
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET.
Huang Y; Fan J; Li Y; Fu S; Chen Y; Wu J
Front Oncol; 2021; 11():731503. PubMed ID: 34557414
[TBL] [Abstract][Full Text] [Related]
8. Radiolabelled probes targeting tumor hypoxia for personalized medicine.
Mees G; Sathekge M; Maes A; Van de Wiele C
Curr Pharm Des; 2014; 20(14):2308-18. PubMed ID: 24025104
[TBL] [Abstract][Full Text] [Related]
9. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.
Georg P; Andrzejewski P; Baltzer P; Daniel M; Wadsak W; Mitterhauser M; Sturdza A; Majercakova K; Karanikas G; Pötter R; Hacker M; Helbich T; Georg D; Pinker K
Mol Imaging Biol; 2018 Feb; 20(1):160-169. PubMed ID: 28540524
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?
Johnson GB; Harms HJ; Johnson DR; Jacobson MS
Semin Nucl Med; 2020 Nov; 50(6):549-561. PubMed ID: 33059824
[TBL] [Abstract][Full Text] [Related]
11.
Grkovski M; Emmas SA; Carlin SD
J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
[TBL] [Abstract][Full Text] [Related]
12. PET and PET/CT studies of tumor tissue oxygenation.
Krause BJ; Beck R; Souvatzoglou M; Piert M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of positron emission tomographic studies for gliomas.
Miyake K; Ogawa D; Okada M; Hatakeyama T; Tamiya T
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):396-408. PubMed ID: 27250577
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity.
Busk M; Munk OL; Jakobsen SS; Horsman MR
Acta Oncol; 2017 Nov; 56(11):1583-1590. PubMed ID: 28840765
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
16. Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
van der Veldt AA; Hendrikse NH; Harms HJ; Comans EF; Postmus PE; Smit EF; Lammertsma AA; Lubberink M
J Nucl Med; 2010 Nov; 51(11):1684-90. PubMed ID: 20956480
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of tumor hypoxia with positron emission tomography.
Kelada OJ; Carlson DJ
Radiat Res; 2014 Apr; 181(4):335-49. PubMed ID: 24673257
[TBL] [Abstract][Full Text] [Related]
18.
Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.
Thorwarth D; Eschmann SM; Scheiderbauer J; Paulsen F; Alber M
BMC Cancer; 2005 Dec; 5():152. PubMed ID: 16321146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
